Cell Signaling Technology

PathScan® Total Cox2 Sandwich ELISA Kit

#7291 · $661

100
Citing papers
12.2k
Combined citations
Supplier page Find this product

Research areas

Cancer-related molecular mechanisms research18Cancer-related gene regulation10Wnt/β-catenin signaling in development and cancer8Autophagy in Disease and Therapy7Circular RNAs in diseases7RNA Interference and Gene Delivery6PI3K/AKT/mTOR signaling in cancer6MicroRNA in disease regulation5

Papers citing this product

1
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Journal of Clinical Oncology·2005·695 cit.·DOI
2
NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts  
Stem Cells·2009·643 cit.·DOI
3
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
Nature Communications·2020·529 cit.·DOI
4
Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
Genes & Development·2010·477 cit.·DOI
5
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
BMC Cancer·2013·436 cit.·DOI
6
The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer
BMC Cancer·2013·410 cit.·DOI
7
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Blood·2011·334 cit.·DOI
8
Activation of Notch1 signaling is required for  -catenin-mediated human primary melanoma progression
Journal of Clinical Investigation·2005·318 cit.·DOI
9
Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer
BMC Cancer·2014·296 cit.·DOI
10
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
Journal of Hematology & Oncology·2019·276 cit.·DOI